BrightSpring Health Services(US:BTSG) Globenewswireยท2025-10-20 20:13Core Insights - BrightSpring Health Services, Inc. reported preliminary financial results for Q3 2025, showing significant revenue growth and improved Adjusted EBITDA guidance [1][2][5] Financial Performance - Total revenue for Q3 2025 reached approximately $3,334 million, a 28.2% increase from $2,601 million in Q3 2024 [5][4] - Gross profit for Q3 2025 was approximately $392 million, up 21.3% from $323 million in Q3 2024 [5][4] - The company achieved a net income of approximately $37.5 million in Q3 2025, compared to a net loss of approximately $25.7 million in Q3 2024 [5][4] - Adjusted EBITDA for Q3 2025 was approximately $160 million, reflecting a 37.2% increase from $117 million in Q3 2024 [5][4] Segment Performance - Pharmacy Solutions revenue for Q3 2025 was $2,967 million, a 31% increase from $2,266 million in Q3 2024 [4][5] - Provider Services revenue for Q3 2025 was $367 million, a 9% increase from $336 million in Q3 2024 [4][5] - Total Adjusted EBITDA for the company was $202 million for Q3 2025, up 33% from $151 million in Q3 2024 [6][5] Future Guidance - The company increased its 2025 revenue guidance to between $12,400 million and $12,700 million, representing a growth of 23.1% to 26.1% compared to 2024 [5][4] - Adjusted EBITDA guidance for 2025 is set between $605 million and $615 million, indicating a growth of 31.5% to 33.7% [5][4] Upcoming Events - BrightSpring will announce full Q3 results on October 28, 2025, and will host a conference call at 4:30 p.m. Eastern Time on the same day [3][1]